53-year-old man was referred to our hospital because of developing exertional dyspnea (NYHA functional class II). His electrocardiogram (ECG) had already shown a negative T wave in leads II, III, aVF, and V1-3 at a physical checkup 2 years before. In cardiac catheterization, left ventriculography had revealed a ventricular aneurysm at the basal posterior segment despite normal coronary arteries. Because no symptoms were apparent, however, a wait-and-see approach had been undertaken for 2 years.
On admission to our hospital, an ECG showed a negative T wave in leads II, III, aVF, and V1-4. Cardiac cine magnetic resonance imaging (MRI) revealed that there was a second aneurysm that was newly developed at the middle anterior segment, in addition to the first aneurysm ( Figure 1 ). An MRI late gadolinium enhancement was present in both of the aneurysms and in the enlarged right ventricle transmurally, whereas a T2-weighted MRI showed normal myocardial signal intensity. Fluorine-18 fluorodeoxyglucose ( 18 F-FDG) positron emission tomography (PET) images obtained after a period of 12 h of fasting showed high FDG accumulation in the basal and apical regions of the left ventricle corresponding to the aneurysms and the hilar lymph nodes ( 
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regional myocardial delayed-enhancement without reference to coronary distribution in MRI 1,2 and uptake in 18 F-FDG PET, 3 and the patient underwent cardiac catheterization. No significant stenosis in the coronary artery was detected and left ventriculography revealed the 2 aneurysms and a severely impaired contraction with an ejection fraction of 25%. An endomyocardial biopsy was performed and it showed a noncaseous epithelioid granuloma with giant cells, supporting the diagnosis of cardiac sarcoidosis. The treatment was started with oral predonisolone of 30 mg/day, and 4 weeks later, 18 F-FDG PET imaging showed marked attenuation of the uptake (Figure 2 ), but MRI showed less changes in the aneurysms and delayed enhancement 1 year later. No recurrence has been detected by 18 F-FDG PET in the subsequent 2 years with a reduced dose of predonisolone. Cardiac sarcoidosis can be an uncommon cause of cardiomyopathy, 4,5 but the existence of a type of cardiac sarcoidosis, which is noticed first by a ventricular aneurysm, should be more widely known. MRI late gadolinium enhancement has been reported to be useful to identify myocardial fibrosis in non-ischemic cardiomyopathy. 6,7 The combination of 18 F-FDG PET and MRI is recommended to detect cardiac involvement of sarcoidosis.
